GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dimerix Ltd (OTCPK:SBMJF) » Definitions » Short Ratio

Dimerix (Dimerix) Short Ratio


View and export this data going back to 2004. Start your Free Trial

What is Dimerix Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Dimerix (Dimerix) Business Description

Traded in Other Exchanges
Address
425 Smith Street, Fitzroy, VIC, AUS, 3065
Dimerix Ltd is a biopharmaceutical company developing innovative new therapies in areas with unmet medical needs. The company is developing five product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for COVID-19 pneumonia patients in ICU; DMX-200 for respiratory complications in Covid-19 patients; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.

Dimerix (Dimerix) Headlines

From GuruFocus

DIMERIX's DMX-200 Posts Strong Results in Kidney Disease Trial

By Business Wire Business Wire 07-29-2020